Oroxylin a Inhibits the Protection of Bone Marrow Microenvironment on CML Cells Through CXCL12/CXCR4/P-gp Signaling Pathway. The gene discussed is CXCR4; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.